Clinical trial
TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in…
NCT00133887 · Hospices Civils de Lyon, Other · Completed
Key facts
| NCT number | NCT00133887 |
|---|---|
| Title | TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients |
| Official title | Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients - Multicentric Randomized, Open-label Study of Rapamycin vs Calcineurin Inhibitors |
| Lead sponsor | Hospices Civils de Lyon, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Skin Cancer, Kidney Transplantation |
| Intervention type | Drug |
| Interventions | rapamycin, ciclosporine, tacrolimus |
| Enrollment | 77 |
| Start date | Apr 1, 2004 |
| Primary completion | Mar 1, 2011 |
| Completion | May 1, 2014 |
| First posted | Aug 24, 2005 |
| Last update posted | Dec 26, 2025 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: